title: [Ventricular fibrillation and cardiorespiratory arrest during dexmedetomidine administration].
authors.affiliation: Servicio de Anestesiología, Hospital Clínico Universitario San Juan de Alicante, San Juan de Alicante, Alicante, España. Electronic address: martetacarrio@gmail.com.
authors.forename: M
authors.initials: M
authors.lastname: Carrió
authors.affiliation: Servicio de Anestesiología, Reanimación y Tratamiento del Dolor, Consorcio Hospital General Universitario de Valencia, Valencia, España.
authors.forename: P
authors.initials: P
authors.lastname: Carmona
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D022561:Advanced Cardiac Life Support; D000368:Aged; D060666:Airway Extubation / Q000009:adverse effects; D001024:Aortic Valve Stenosis / Q000601:surgery; D020927:Dexmedetomidine / Q000009:adverse effects* / Q000627:therapeutic use; D057915:Drug Substitution; D004554:Electric Countershock; D006323:Heart Arrest / Q000139:chemically induced* / Q000628:therapy; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D007022:Hypotension / Q000188:drug therapy / Q000209:etiology; D008297:Male; D011183:Postoperative Complications / Q000139:chemically induced* / Q000188:drug therapy; D015742:Propofol / Q000627:therapeutic use; D011595:Psychomotor Agitation / Q000188:drug therapy*; D014693:Ventricular Fibrillation / Q000139:chemically induced* / Q000628:therapy
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine; D015742:Propofol